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ABSTRACT
Introduction This paper outlines the study protocol for 
the Dutch Young People (YP) Face IT Study. Adolescents 
with a visible difference (ie, disfigurement) often 
experience challenging social situations such as being 
stared at, receiving unwanted questions or being teased. 
As a consequence, some of these adolescents experience 
adverse psychosocial outcomes and appearance- related 
distress. To address this appearance- related distress, an 
online psychotherapeutic intervention, YP Face IT, has 
been developed. YP Face IT uses social interaction skills 
training and cognitive–behavioural therapy. The Dutch YP 
Face IT Study tests whether this intervention is effective in 
reducing social anxiety and improving body esteem.
Methods and analysis Participants are adolescents 
aged 12–18 with a visible difference and experiencing 
appearance- related distress. In this two- armed 
randomised controlled trial, 224 adolescents will be 
randomised to care as usual or YP Face IT. Adolescents 
will complete questionnaires at baseline, at 13 weeks and 
at 25 weeks. Primary outcomes are differences in social 
anxiety and body esteem between YP Face IT and care as 
usual. Secondary outcomes are differences in aspects of 
self- worth, perceived stigmatisation, health- related quality 
of life, life engagement, appearance- related distress and 
depressive symptoms between the two groups.
Ethics and dissemination Research ethics approval 
was obtained from the medical ethics review committee 
in Rotterdam (reference number MEC-2018-052/
NL63955.078.18). Findings will be disseminated through 
academic peer- reviewed publications, conferences and 
newsletters to patient associations and participants of the 
study.
Trial registration number The Netherlands Trial Register 
(NL7626).
INTRODUCTION
Having a visible difference can have a 
substantial impact on one’s life. People with 
a visible difference commonly encounter 
difficult social situations, such as being 
stared at, receiving unwanted questions and 
feeling isolated. A visible difference (ie, 
disfigurement) to the face or body occurs in 1 
in 44 people, a visible difference solely to the 
facial area in 1 in 111.1 A visible difference 
can be either congenital (eg, cleft lip and 
palate and craniofacial conditions), result 
from a skin condition (eg, vitiligo, psoriasis 
and acne), trauma (eg, burns and scars), 
disease (eg, cancer, meningitis and alopecia 
areata) or medical treatment (eg, surgery 
or radiotherapy). Whether someone identi-
fies as having a visible difference is a subjec-
tive experience. A clear definition of what a 
visible difference is can thus not be given.
Some studies show that adolescents with a 
visible difference experience no additional 
psychosocial problems2 3 and even perceive 
their friendship, social acceptance, appear-
ance and emotional distress in a more positive 
way than unaffected peers.4 However, reviews 
show that a significant number of adolescents 
with a visible difference do experience adverse 
psychosocial outcomes.5–7 More specifi-
cally, they experience higher levels of minor 
psychological disturbance, self- consciousness 
in public situations, neuroticism,8 internal-
ising symptoms7 9 and anxiety, depression 
and difficulties with social functioning.10 
Furthermore, parents perceive their children 
as being more shy and inhibited.11
Strengths and limitations of this study
 ► This is the first randomised controlled trial to assess 
Young People Face IT, an online psychosocial inter-
vention for adolescents with a visible difference.
 ► Measurements include a direct follow- up and follow- 
up 3 months after completion of the intervention.
 ► Participants are recruited throughout the 
Netherlands, enhancing generalisability.
 ► Participants are not blinded to allocation, which 
could lead to reporting bias.
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Available interventions for adolescents or adults with a 
visible difference are scarce and lack evidence base.12–15 
Research often lacks a solid design and overall method-
ological quality and yields small effect sizes. However, there 
is some support for models involving social skills training 
(SST), cognitive–behavioural therapy (CBT)12 14 15 and 
self- help for managing anxiety.13
Young People (YP) Face IT was developed in the UK, in 
collaboration with adolescents and the charity Changing 
Faces.16 YP Face IT was derived from the adult interven-
tion Face IT, which was found to be effective at reducing 
anxiety, depression and appearance concerns while 
increasing positive adjustment.17 In an acceptability and 
feasibility study concerning YP Face IT, the intervention 
was found to be acceptable, with most of the adolescents 
thinking it would help them improve their confidence 
and self- acceptance and help them develop new skills in 
dealing with difficult social situations.16
Aims
In sum, interventions aimed at adolescents with a visible 
difference are scarce and have limited evidence to support 
them. The available evidence, however, does point to 
SST and CBT as being potentially effective methods for 
managing psychosocial difficulties among people with a 
visible difference. In an attempt to provide adolescents 
coping with a visible difference with an effective inter-
vention focussing on improving emotional resilience, the 
Dutch YP Face IT Study aims to test an online psychother-
apeutic intervention combining social interaction skills 
training (SIST) and CBT. More specifically, the aims of 
the current study are to test the effectiveness of the Dutch 
version of YP Face IT in reducing anxiety and improving 
body- esteem among Dutch adolescents with a visible 
difference.
METHODS AND ANALYSIS
To assess the effectiveness of the Dutch version of YP 
Face IT, a randomised controlled trial (RCT) will be 
conducted.
Participants
This study will be conducted in a Dutch academic 
hospital. The target group for this study is Dutch adoles-
cents aged 12–18 with a visible difference and experi-
encing appearance- related distress. Recruitment will take 
place throughout the Netherlands.
Adolescents will be eligible for participation if they 
are aged between 12 and 18, have a visible difference 
and access to a computer with internet and experience 
appearance- related distress. The appearance- related 
distress is operationalised as an elevated score on either 
social anxiety or depression or a lower score on body 
esteem, as assessed by self- reports.
Exclusion criteria are a mental disability, reading ability 
below 12 years of age, visual impairments preventing 
comprehension of the online intervention, a clinical 
diagnosis of depression, psychosis, body dysmorphic 
disorder or an eating disorder and insufficient profi-
ciency of Dutch. Furthermore, adolescents who receive 
face- to- face care by a psychologist will be excluded from 
participation.
Intervention
YP Face IT (Dutch: Face IT voor jongeren) is an online 
psychotherapeutic intervention16 specifically designed 
for adolescents and developed in cooperation with 
adolescents and the British charity Changing Faces. The 
intervention is aimed at helping adolescents cope with 
some key concerns people with a visible difference may 
have, such as anxiety, depression, low self- esteem and 
appearance- related distress.
YP Face IT combines SIST with CBT. The intervention 
consists of 7 weekly sessions and an additional booster 
session after 6 weeks, helping the adolescent recall what 
was learnt during the weekly sessions. The first three 
sessions focus on SIST, sessions 4–6 focus on CBT and 
session seven is a summary of all learnt techniques. 
Session eight is a booster quiz, 6 weeks after session seven. 
The content of each session is displayed in table 1. Each 
session has different exercises and activities and takes 
45–60 min to complete. In addition to the weekly sessions, 
participants will also be asked to complete small home-
work assignments between sessions. Participants will have 
access to an online journal in which they can write about 
their experiences and enter the answers to the home-
work assignments. Participants will have the opportunity 
to contact the research team if they are struggling with 
the homework activities. A reminder email is send if the 
participant has not entered data relating to the home-
work activity in their journal within 5 days following their 
last session.
YP Face IT is designed as a self- help intervention, 
without any active guidance by a psychologist. Adolescents 
work through the sessions on their own. Parents receive 
a short description of each session and will receive the 
reminders, but are not involved in the sessions themselves.
Monitoring will take place to assess whether adolescents 
complete the homework assignments and whether they 
are struggling in any way with the intervention or their 
mental health. Monitoring will be done by an experi-
enced clinical psychologist and a master’s student. Should 
we find that adolescents experience severe psychological 
symptoms, they are referred to other care that may better 
suit their needs.
Care as usual (CAU)
CAU will consist of regular medical care. The type 
of the care may differ depending on the condition 
(eg, skin care for eczema and orthodontics for cleft 
palate). Psychological care is not part of CAU. However, 
medical personnel will monitor the adolescents’ well- 
being as part of CAU. They may refer the adolescents 
to a psychologist in case of suspicions of psychological 
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problems. Adolescents that receive psychological care 
during participation in the study will not be allowed 
further participation.
Materials
All outcome measures are completed at all three time 
points.
Primary outcomes
Social anxiety. The Social Anxiety Scale for Adolescents 
(SAS- A)18 will be used to assess social anxiety. The SAS- A 
contains 22 statements that are rated on a five- point 
Likert Scale (eg, I worry about what others say about me; 
I get nervous when I meet new people). A high score 
indicates high levels of social anxiety. The SAS- A contains 
three subscales, namely, fear of negative evaluation 
(FNE), social avoidance and distress in new situations 
(SAD- new) and social avoidance and distress in general 
(SAD- general). Cronbach’s alphas are satisfactory for 
the subscales, being α=0.91, 0.83 and 0.76, respectively.18 
Further research also yielded satisfactory Cronbach’s 
alphas of α=0.89, 0.80 and 0.70 for FNE, SAD- new and 
SAD- general respectively.19
Body esteem. The subscale ‘appearance’ from the Body 
Esteem Scale For Adolescents and Adults (BESAA)20 is 
used to assess participant’s attitudes and feelings about 
their appearance. A higher score indicates more satis-
faction with one’s appearance. This subscale consists 
of 10 statements, such as ‘I like how I look in photos’. 
The items are rated on a five- point Likert Scale ranging 
from ‘never’ to ‘always’. The subscale demonstrates excel-
lent internal consistency in a sample of American girls 
(α=0.92) and boys (α=0.90)21 and in a sample of Dutch 
university students (α=0.90).22
Secondary outcomes
Aspects of self- worth. The Dutch version of the Self- 
Perception Profile for Adolescents,23 the Competen-
tiebelevingsschaal voor Adolescenten (CBSA),24 will 
be used to assess different aspects of self- worth. The 
CBSA consists of eight specific domains and a global 
self- worth subscale. The specific domains are scholastic 
competence, social competence, athletic competence, 
physical appearance, job competence, romantic appeal, 
behavioural conduct and close friendship. The CBSA 
consists of 35 items, each consisting of two contrasting 
statements (eg, some teenagers are not happy with the 
way they look, BUT other teenagers are happy with the 
way they look). The adolescent is asked to pick the state-
ment that is most representative of them and choose 
whether the statement is ‘sort of true for me’ or ‘really 
true for me’. All domains demonstrate good to excellent 
internal reliabilities, ranging from α=0.74 to α=0.93. The 
global self- worth subscale also demonstrates excellent 
reliability, with α=0.80–0.89.23
Perceived stigmatisation. The Perceived Stigmatisation 
Questionnaire (PSQ)25 will be used to measure stigmatisa-
tion behaviours commonly experienced by people with a 
visible difference. The PSQ is divided into three subscales, 
namely, absence of friendly behaviour, confused/staring 
behaviour and hostile behaviour. These subscales amount 
to a total of 21 items concerning stigmatising behaviours, 
such as ‘people avoid looking at me’ and ‘people call 
me names’. Participants are asked to rate how often they 
experience certain behaviour on a five- point Likert Scale. 
A high score reflects high perceived stigmatisation. The 
three subscales have been established,26 and the PSQ has 
adequate reliability in a sample of children and adoles-
cents with a visible difference (α=0.81).27
Table 1 Content of the YP Face IT intervention
Session Content Type Week
1. Common problems Common problems experienced by adolescents with a visible 
difference: bystander responses, teasing, bullying.
SIST 1
2. Improve your social skills Body language, verbal and non- verbal skills and building 
positive social skills.
SIST 2
3. Don’t be SCARED, REACH OUT Effect of own behaviour on other people. Toolbox of techniques 
to cope with difficult social situations.
SIST 3
4. Think, Feel, Do Relationship between thoughts, feelings and behaviours. 
Identifying negative thoughts and using a positive voice to 
challenge these thoughts. Different coping strategies for 
negative thoughts.
CBT 4
5. SMART goals Using SMART goals to help achieve goals, dividing the end goal 
into subgoals. Dealing with concerns in romantic relationships.
CBT 5
6. Beating anxiety Exposure therapy in the form of a fear ladder. Relaxation 
techniques.
CBT 6
7. Looking at your progress Summary session, with summary of all previous sessions. SIST/CBT 7
8. Booster quiz Quiz with 16 questions on all taught techniques. SIST/CBT 13
CBT, cognitive–behavioural therapy; SIST, social interaction skills training; YP, Young People.
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Health- related quality of life. The EuroQol- 5D- 5L 
(EQ- 5D- 5L)28 is used to assess health- related quality 
of life. The scale has five dimensions, namely, mobility, 
self- care, usual activities, pain/discomfort and anxiety/
depression. Each dimension can be assessed on five levels, 
which range from no problems to extreme problems. The 
EQ- 5D- 5L has good absolute and relative discriminatory 
power and good convergent validity.29
Life engagement. The Life Engagement Scale30 will be 
used to measure the extent that worries or feeling bad 
about the way you look stops you from engaging in life 
activities such as going to a social event or doing sports. 
The scale consists of ten questions on which the adoles-
cent can rate how much their worries or feeling bad about 
the way they look stopped them from doing activities on 
a four- point scale. A high score indicates less life engage-
ment. This instrument was purposively constructed for 
adolescents with a visible difference. The scale has good 
internal consistency, with α=0.93 for girls and α=0.96 for 
boys.30
Appearance- related distress. The Mirror, Mirror (Spiegeltje, 
Spiegeltje)31 Questionnaire will be used to assess 
appearance- related distress. This questionnaire consists 
of 58 statements about appearance (eg, my appearance 
makes me insecure), with a five- point Likert Scale ranging 
from ‘never’ to ‘always’. The questionnaire also contains 
a section with 38 body parts where adolescents have to 
indicate on a five- point Likert Scale how happy they are 
with said body part (eg, skin colour and the mouth). A 
high score indicates more dissatisfaction with appear-
ance. As this questionnaire is new and unpublished, it has 
not been validated. We aim to validate this questionnaire 
using the data obtained in this study.
Depressive symptoms. The Child Depression Inventory-2 
(CDI-2)32 will be used to assess depressive symptoms. 
The questionnaire consists of 28 items with three answer 
options (eg, I am sad sometimes, I am often sad and I am 
always sad). The scale consists of the subscales emotional 
problems, divided into negative mood/physical symp-
toms and negative self- esteem, and functional problems 
divided into ineffectiveness and interpersonal problems. 
A high score indicates more depressive symptoms. The 
questionnaire has demonstrated excellent internal reli-
ability both for 13–16 year olds (α=0.89) and for 17–21 year 
olds (α=0.85).32 The scale has good test–retest reliability 
(r=0.60).32
Recruitment
Participants are recruited through several channels. The 
first is through patient organisations. Patient organisa-
tions will be approached and asked if they are willing to 
advertise the Dutch YP Face IT Study on their website 
and in their newsletters. If an adolescent is willing to 
participate, he/she is encouraged to send an email to 
the research team, providing his/her contact details. 
The adolescent will then receive an information package 
containing a patient information letter, an informed 
consent form and a response card. The second channel 
is through our website ( www. faceitvoorjongeren. nl). On 
our website, adolescents can read information about YP 
Face IT and contact the research team. If they do so, they 
will receive an information package. The third channel 
is through the Erasmus MC- Sophia Children’s Hospital. 
Subjects will be drawn from the department of child and 
adolescent psychiatry/psychology, the department of 
plastic and reconstructive surgery, the department of oral 
and maxillofacial surgery and special dental care and the 
department of dermatology. Subjects will be informed 
about the study by their treating doctor/clinician. It will 
be explicitly stated that participation is voluntary and that 
they can withdraw from the study at any time should they 
wish to do so. After informing the potential participant, 
they will receive an information package. If a potential 
participant does not have regular appointments at the 
Erasmus MC- Sophia Children’s Hospital, we will send an 
information package to their home address.
A response card will be included in the information 
package. On this response card, adolescents can indi-
cate whether they give permission to be contacted by 
the research team. If the response card has not been 
returned within 2 weeks, the research team will contact 
the adolescent.
If participants are willing to participate, they are asked 
to fill in a consent form. For participants younger than 
16 years, both parents are required to sign the informed 
consent form. After receiving the informed consent form, 
the researchers will include the participant in the trial 
and send out the first set of online questionnaires.
Participants will receive a gift card worth €10, after 
completing the entire study. If a participant decides to 
withdraw from the study prematurely, the adolescent will 
not receive a gift card.
Study design
A flow chart of the RCT is depicted in figure 1. Prior 
to baseline, the inclusion and exclusion criteria as 
mentioned before (with the exception of appearance- 
related distress) are queried in a telephone call with 
the parent or adolescent. Appearance- related distress is 
measured based on the questionnaires completed at T1 
(baseline). Adolescents will receive an email with a link to 
all questionnaires, with the exception of the CBSA. They 
will receive this questionnaire by post. This procedure is 
the same for T2 (13 weeks, direct follow- up) and T3 (25 
weeks, 3- month follow- up).
After completing the questionnaires, screening for 
appearance- related distress will take place by the research 
team. The scores on the SAS- A, BESAA and CDI-2 are 
considered. For the SAS- A and the BESAA, adolescents 
that score 0.5–2.0 SD above average will be included 
in the study. For the CDI-2, we will include adolescents 
scoring in the 70th–90th percentile, as the manual states 
that this corresponds to subclinical symptoms of depres-
sion.32 Adolescents that score within the defined range 
for one or more of the questionnaires will be randomised 
into the study. Adolescents that score below this range will 
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be excluded from participation. Adolescents that score 
above this range will be contacted by the research team 
to assess whether there are clinical psychological symp-
toms. A phone call is made to both the adolescent and 
one of his/her parents. During this phone call, the Diag-
nostic and Statistical Manual of Mental Disorders (DSM) 
criteria for depressive disorder, social anxiety disorder or 
another suspected diagnosis will be asked. If suspicions of 
clinical psychological symptoms arise, the adolescents are 
referred to the appropriate psychological care. If no clin-
ical symptoms are present, the adolescent is randomised 
into the study.
Adolescents with subclinical symptoms will be 
randomised to either CAU or YP Face IT. Adolescents 
in the CAU group will receive CAU and will complete 
T2 at 13 weeks and T2 at 25 weeks. The CAU group will 
have the opportunity to complete YP Face IT after their 
participation in the study. Adolescents in the YP Face IT 
group will receive CAU and YP Face IT and will complete 
questionnaires immediately after completing YP Face IT 
(T2; 13 weeks) and 3 months after completing YP Face IT 
(T3; 25 weeks).
Randomisation and blinding
Participants will be randomised to either the CAU or 
the YP Face IT group in a 1:1 ratio. Randomisation will 
be stratified by age (12–13, 14–15 or 16–17 years old). 
Randomisation will be done using a list with a random 
sequence, generated using a computer programme. 
With the stratification, six different types of blocks can 
be formed. Each block will independently vary between 
four and eight randomisation pairs. The adolescents are 
informed of the group they are randomised to through 
email. The researcher analysing the data will be blind to 
the randomisation and will not be involved in monitoring 
the adolescents in the intervention. This researcher 
also supervises data collection by students, who are not 
blinded. The participants, the clinical psychologist and 
Figure 1 . Flow chart of the study design. CAU, care as usual; YP, Young People.
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students monitoring the adolescents in the interven-
tion will not be blind to the treatment conditions. When 
contacting the research team, the adolescents are explic-
itly instructed not to talk about the group they were allo-
cated to.
If, through monitoring, the research team suspects 
that a participant experiences clinically significant symp-
toms, unblinding may take place. The participant will be 
excluded from the study and will be transferred to more 
appropriate care.
Participants that drop out after randomisation will be 
asked if they are willing to complete the questionnaires at 
T2 and T3. They are in no way obliged to do so.
Sample size
For the sample size calculation, we applied a mixed- 
model Analysis of Variance (ANOVA) procedure, with a 
power of 0.80, a two- sided alpha of α=0.025 (Bonferroni 
corrected for two primary outcome measures), a correla-
tion between the repeated measurements of r=0.70 and 
three repeated linearly decreasing measurements. Bessell 
and colleagues17 reported effect sizes of d=0.83 for 
appearance and d=0.80 for anxiety in a study on Face IT. 
However, as we are not certain that we will obtain such a 
large effect, we will consider a medium effect of d=0.50. 
To detect a medium effect, 56 participants are needed in 
both groups. As dropout is typically high in eHealth inter-
ventions,33 34 we anticipated a dropout of 50%. Therefore, 
224 participants are needed in total.
Statistical analysis
The data will be analysed using multilevel linear regres-
sion analyses. There will be two levels in the models. The 
participants constitute the upper level and their repeated 
measures the lower level. For each outcome variable, a 
model will be postulated using treatment group, time and 
interaction with treatment group as fixed effects. Time 
will be entered in two ways: categorical and continuous. 
First, for categorical, we will postulate a model with T2 
(direct follow- up) and T3 (3- month follow- up) using T1 
(baseline) as reference group. Second, for continuous, we 
will apply the logarithm of time, as generally treatments 
have the largest effect at start and the level of functioning 
stabilises on the long run. The deviance statistic using 
restricted maximum likelihood will be applied to deter-
mine the covariance structure. The deviance test will be 
used to determine whether the more parsimonious (log) 
model is a too rigorous oversimplification.35 Effect sizes 
will be calculated from dividing differences between the 
primary time point (ie, 3 months) estimations and base-
line by the estimated baseline SD. Analyses are done on 
an intention- to- treat base.
Participants who do not experience subclinical symp-
toms at T1, and are thus not randomised, will not be 
included in the analyses.
Monitoring
As the risks associated with this study are minimal, 
monitoring will take place once a year. An independent 
investigator will randomly check study documents, partic-
ipant selection and participant safety. As minimal risks are 
involved, no interim analyses will be done.
Auditing may be done by the Erasmus MC- Sophia Chil-
dren’s Hospital.
Patient and public involvement (PPI)
The original YP Face IT intervention was developed in 
collaboration with adolescents and the charity Changing 
Faces.16 For the Dutch translation, six adolescents and 
their parents have read and reviewed the translations. 
Prior to this RCT, an acceptability and feasibility study 
was conducted. In this study, 14 adolescents completed 
YP Face IT and participated in an interview. Feedback was 
asked on the intervention, as well as on the general study 
procedures (ie, information packages, questionnaires 
and contact with the research team). Patient associations 
will be invited to help develop our dissemination strategy.
Trial status
The trial described in this paper has started in September 
2019. Recruitment of participants will be until November 
2020. Data collection will be until May 2021, after which 
the data will be analysed.
ETHICS AND DISSEMINATION
Ethics, consent and permission
This study will be conducted in accordance to the Decla-
ration of Helsinki.
Research ethics approval was obtained from the 
medical ethics review committee in Rotterdam (reference 
number MEC-2018-052/NL63955.078.18). Any amend-
ments to the study protocol and (serious) adverse events 
will be reported to this committee.
Data management and confidentiality
To ensure anonymous processing of the data, every partic-
ipant will receive a study number. All research data will be 
processed using only this study number. The handling of 
data will comply with the European General Data Protec-
tion Regulation. The study master file and all research 
data will be saved for 15 years, unless participants or their 
parents/guardians do not give consent for saving their 
data.
All data will be stored in locked cabinets or password- 
protected documents. The data, including the final 
dataset, can be accessed only by members of the research 
team.
Dissemination of research findings
Results of this study will be presented on national and 
international conferences and in peer- reviewed scien-
tific journals, within the scope of the target groups. The 
results will also be relayed to patients through patient 
organisations. Participants are also given the option to 
sign up for a brief study report after the results are final-
ised. If deemed effective, YP Face IT will be implemented 
in hospitals in the Netherlands.
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DISCUSSION
The Dutch YP Face IT Study aims to test the Dutch version 
of YP Face IT. With this RCT, we aim to retrieve data on 
the effectiveness of the intervention.
Strengths and limitations
A particular strength of this study is that it follows a stage 
model of behavioural therapies research36 and has excel-
lent methodological quality. Previous research has lacked 
methodological rigour, due to small sample sizes, not 
including a control group or not blinding personnel or 
participants.15 Due to the nature of this study, blinding 
of participants is not possible. However, this study does 
include an adequate sample size and includes a control 
group and blinding of relevant personnel. With this 
methodological quality, we hope to be able to provide 
evidence base for YP Face IT and thus provide one of 
the first evidence- based treatments for adolescents with 
a visible difference.15 Furthermore, by recruiting our 
participants through several channels, we will be able to 
obtain a sample that is representative for Dutch adoles-
cents in general rather than solely Rotterdam, where the 
research team is located. Because the intervention is avail-
able online, participants throughout the entire country 
are able to participate without adding extra burden to 
participating.
In addition to strengths, this study also has some limita-
tions. First, the intervention is available for a range of 
conditions causing a visible difference. The overall group 
results might not be generalisable to one specific group. 
Second, participants are not blind to the treatment condi-
tion. Participants are informed about the randomisation 
groups. They are also informed that, if randomised to 
the CAU group, they will have the possibility to access YP 
Face IT after the study. This is a more ethical option than 
not offering treatment after the study, and this knowl-
edge may help keep attrition low. However, waiting- list 
designs may lead to an overestimate of the treatment 
effect.37 Furthermore, this study includes only self- report 
measures. Diagnostic interviews or parent reports could 
provide more enriched data. However, due to time and 
financial constraints, these data will not be collected.
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